Godrej Consumer Product Q4 net Profit

Godrej Consumer Products Ltd has announced the following results for the quarter & year ended March 31, 2016.

The company has posted a net profit of Rs. 310 crore for the Quarter ended March 31, 2016 as compared to Rs. 265.5 crore for the Quarter ended March 31, 2015. The company's total income has increased from Rs. 2,109.4 crore for the Quarter ended March 31, 2015 to Rs. 2,283.3 crore for the Quarter ended March 31, 2016.

The audited consolidated results for the Year ended March 31, 2016:

The company has posted a net profit of Rs. 1119.4 crore for the year ended March 31, 2016 as compared to Rs. 907.1 crore for the year ended March 31, 2015. The company's total income has increased from Rs. 8367.8 crore for the year ended March 31, 2015 to Rs. 9034.6 crore for the year ended March 31, 2016.

The audited standalone results for the Quarter ended March 31, 2016:

The company has posted a net profit of Rs. 2111.40 million for the quarter ended March 31, 2016 as compared to Rs. 1880.60 million for the quarter ended March 31, 2015. Total Income has increased from Rs. 11579.50 million for the quarter ended March 31, 2015 to Rs. 12343.20 million for the quarter ended March 31, 2016.

The audited standalone results for the Year ended March 31, 2016:

The company has posted a net profit of Rs. 7397.20 million for the year ended March 31, 2016 as compared to Rs. 6544.50 million for the year ended March 31, 2015. Total Income has increased from Rs. 44850.40 million for the year ended March 31, 2015 to Rs. 48543.80 million for the year ended March 31, 2016.

Stock view:

Godrej Consumer Products Ltd is currently trading at Rs. 1374.55, up by Rs. 4.35 or 0.32% from its previous closing of Rs. 1370.2 on the BSE.

The scrip opened at Rs. 1380 and has touched a high and low of Rs. 1393 and Rs. 1360 respectively. So far 208712(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 46659.94 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1456.65 on 03-Aug-2015 and a 52 week low of Rs. 1024 on 04-May-2015. Last one week high and low of the scrip stood at Rs. 1374 and Rs. 1310 respectively.

The promoters holding in the company stood at 63.28 % while Institutions and Non-Institutions held 30.43 % and 6.29 % respectively.

The stock is currently trading above its 50 DMA.

Tata Motors gains 2 % on April auto sale

Tata Motors stock was up by 2% at Rs. 417. The company saw Y-o-Y sales growth of 9.9% for total commercial and passenger vehicles sales (including exports) in April 2016 at 39,763 vehicles, over 36,190 vehicles sold in April 2015. 

The scrip opened at Rs. 411.4 and has touched a high and low of Rs. 418.4 and Rs. 410.6 respectively. So far 1157848(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 132606.03 crore.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 530.95 on 11-May-2015 and a 52 week low of Rs. 266 on 11-Feb-2016. Last one week high and low of the scrip stood at Rs. 425 and Rs. 395 respectively.

The promoters holding in the company stood at 33.01 % while Institutions and Non-Institutions held 41.3 % and 25.69 % respectively.

The stock is currently trading above its 200 DMA.

LIC has bad loans of well over Rs. 12,000 cr

Life Insurance Corporation (LIC) has non-performing assets (NPAs) worth INR 12,230 crore, or 3.3 per cent of its total debt, according to 2014-15 annual report.

This had risen to 4.23 per cent as of December 2015. 

These figures are close to those reported by a few banks during the October-December quarter - SBI (5.1 per cent of loans), ICICI Bank (4.7 per cent), Syndicate Bank (4.6 per cent) and Vijaya Bank (4.32 per cent).

In 2010-11, LIC's Gross NPAs (GNPAs) stood at just 0.95 per cent of its total debt. 

LIC’s total debt of about INR 3,70,625 crore as of March 2015, was higher than HDFC Bank’s loan book of about Rs. 3,65,495 crore in FY15.

Apart from its investments in debentures and bonds, LIC has extended loans to the Centre, State Governments, banks, financial institutions (FI) and companies, which amounted to about INR 1 lakh crore as of March 2015.

Asian stock markets mixed; shanghai composite is up 1.5%

Asian stock market​s​ ​are ​trading on a mixed note despite disappointing data from China, with banks leading Australia's shares higher. Japan is closed for the day.

The Caixin General China Manufacturing Purchasing Managers' Index (PMI), an indicator of manufacturing activity, edged down to 49.4 in April. China’s Shanghai Composite is currently trading 1.62% higher at 2,986.25 points.

South Korea’s Kospi index ​is ​at 1,986.17 points (up 0.40%) and Indonesia’s Jakarta Composite ​is ​at 4,821.99 points (up 0.29%)

On the losing front, Taiwan’s Taiex at 8,300.78 points (down 0.93%), Singapore’s Straits Times at 2,818.07 points (down 0.73%), Hong Kong’s Hang Seng at 20,813.65 points (down 1.22%), Thailand’s SET Composite at 1,402.91 points (down 0.12),  and Singapore Nifty at 7,830 points (down 0.11).

US stock indices advanced on Monday with the Nasdaq Composite index breaking its seven-session losing streak.

Stocks in focus today stock to watch

Tata Motors: Tata Motors saw Y-o-Y sales growth of 9.9% for total commercial and passenger vehicles sales (including exports) in April 2016 at 39,763 vehicles, over 36,190 vehicles sold in April 2015.

Adani Ports and Special Economic Zone Ltd: Adani Ports and Special Economic Zone (APSEZ), one of the leading firms in post sector in India, will announce its Q4 number today. IIFL estimates that the company’s net profit is likely to dip to Rs. 656 crore, at a rate of 0.5% yoy; however, the same is expected to surge 2.8% qoq.

NALCO: The company has agreed to buy back 25 percent of its shares from the government, as per media reports.

Mahindra & Mahindra: The company reported its total sales stood at 41,863 units in April 2016 compared to 36,727 units in April 2015, recording a growth of 14%.
  
Future Group: Skechers India will increase its stake in its joint venture (JV) with Kishore Biyani from 49 per cent to 51 per cent, reports a business daily.

Blue Star: Blue Star said that it will challenge a Rs. 135.72 crore service tax and penalty imposed on it at an appropriate forum. The company termed it as a "patently erroneous" step by tax authorities.

TVS Motor Company: The company's total exports registered sales of 28,354 units in the month of April 2016 as against 32,426 units in April 2015.

Indraprastha Gas Ltd: The oil company has set up a record 72 CNG filling stations in first four months of 2016, to meet the rising demand for the fuel.

Maruti Suzuki Ltd: Maruti Suzuki Ltd has created a new management level as the country's largest car maker seeks to build management and leadership bandwidth for the future, reports a business daily.

IOC: Indian Oil Corporation Ltd has informed BSE that in accordance with the approval accorded by Cabinet Committee on Economic Affairs on May 13, 2013, Government of India (GOI) has offered 1,21,39,762 Equity Shares of Rs. 10/- each to the eligible employees of Indian Oil at a discounted price of Rs. 367.65 per share (5% discount to the cut off price of Rs. 387/- discovered through the Offer For Sale of equity shares of IndianOil carried out by GOI on August 24, 2015).

Hero MotoCorp:  The company sold 612,739 units of two­ wheelers in April, registering a sturdy doubledigit growth of 15% over the corresponding month last year when the company had sold 533,305 units.

Alembic Pharma: The company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide Tablets, SO mg, 100 mg, lSO mg and 200 mg.

CCL Products: The company’s consolidated revenue stood at Rs. 264.49 crore, up 22.22% yoy and 24.21% qoq.

Apollo Hospitals: Apollo Hospitals has signed a memorandum of understanding with William Osler Health System (Osler) to collaborate on research and treatement services related to a range of diseases including Diabetes, Cardiovascular Diseases and Cancer.

Marksans Pharma: Marksans Pharma has received approval from the US health regulator for its Metformin Hydrochloride tablets, used for treatment of diabetes, in the American market.